What is MKKGY stock price today?

MKKGY (Merck KGaA ADR) stock is trading at $29.41 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MKKGY stock going up or down today?

MKKGY stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MKKGY stock now?

The decision to buy MKKGY depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MKKGY a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MKKGY based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MKKGY stock overvalued or undervalued?

MKKGY currently trades at a P/E ratio of 19.09 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if MKKGY is fairly priced.

What is MKKGY's P/E ratio?

MKKGY has a price-to-earnings (P/E) ratio of 19.09, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is MKKGY's market cap?

MKKGY (Merck KGaA ADR) has a market capitalization of $65.59 billion, making it a mid-cap stock.

What is MKKGY's price to book ratio?

MKKGY trades at a price-to-book (P/B) ratio of 1.95, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does MKKGY pay dividends?

Yes, MKKGY pays dividends with a current yield of 0.07%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is MKKGY's dividend yield?

MKKGY's dividend yield is 0.07%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is MKKGY stock a good long-term investment?

MKKGY's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MKKGY's revenue growth rate?

MKKGY has shown revenue growth of 0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, MKKGY is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.

What are the risks of investing in MKKGY?

Key risks for MKKGY include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MKKGY compare to its competitors?

Compare MKKGY to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MKKGY's performance and positioning.

What is MKKGY's stock price target for 2026?

Our AI model provides price targets for MKKGY based on fundamental analysis: Bull case $38.23 (+30%), Base case $33.82 (+15%), Bear case $26.47 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MKKGY?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MKKGY. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MKKGY's next earnings report?

MKKGY reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MKKGY - Merck KGaA ADR

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$29.41

$-0.76 (-2.52%)

About Merck KGaA ADR

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography resins, single-use systems, process chemicals, and excipients; and life science services, such as monoclonal antibodies, high-potency active pharmaceutical ingredients, antibody-drug conjugates, and viral and gene therapy products, as well as contract development, manufacturing, and testing services. Its Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, cardiovascular, metabolism, and endocrinology disorders; and provides general medicines, injection devices, and disease monitoring software. The Electronics segment supplies materials comprising thin films, patterning and planarization formulations, specialty gases, optronics, and optical metrology equipment for the semiconductor and display industries, as well as provides delivery systems and services. It has in-licensing agreements with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA is a subsidiary of E. Merck KG.

MKKGY Key Statistics

Market Cap

$65.59B

P/E Ratio

19.09

P/B Ratio

1.95

EPS

$1.58

Dividend Yield

0.07%

Revenue Growth

+0.0%

Profit Margin

0.1%

Employees

62,346

How MKKGY Compares to Peers

MKKGY is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MKKGY(This stock)	$65.59B	19.1	0%	0.1%	-
LLYEli Lilly	$933.47B	51.0	1%	0.3%	vs LLY
JNJJohnson &	$525.73B	21.1	0%	0.3%	vs JNJ
PFEPfizer Inc	$145.10B	14.8	-0%	0.2%	vs PFE
MRKMerck &	$273.38B	14.5	0%	0.3%	vs MRK
ABBVAbbvie Inc	$378.29B	160.9	0%	0.0%	vs ABBV

Merck KGaA ADR Company Information

Headquarters: Frankfurter Strasse 250, Darmstadt, Germany, 64293, undefined
Website: www.emdgroup.com
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

About Merck KGaA ADR

MKKGY Key Statistics

How MKKGY Compares to Peers

Merck KGaA ADR Company Information

Upcoming Events for MKKGY